HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Minoxidil Plus seizure Aug. 3 is latest action in long-running Upjohn v. Medtron case.

This article was originally published in The Rose Sheet

Executive Summary

MINOXIDIL PLUS PRODUCT SEIZURE AUG. 3 IN NEW YORK CITY is the latest action in a long-running legal effort by Upjohn to bar a Manhattan salon from capi-talizing on Rogaine labeling for treatment of hair loss. The seizure of "Minoxidil Plus" came after Manhattan Federal Court Judge Shirley Wohl Kram ruled July 19 that the Hair & Skin Treatment Center (formerly New York Hair Labs, formerly Medtron) was in contempt of the court's 1990 and 1992 injunctions enjoining the defendant from the "manufacturing, sale, distribution, advertisement, and promotion" of products covered by Upjohn's Rogaine patents.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001905

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel